Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PsyBio Therapeutics (TSE:PSYB.H)
TSXV:PSYB.H
Holding TSE:PSYB.H?
Track your performance easily
PSYB.H Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week Range<C$0.01 - C$0.02
Previous CloseC$0.01
VolumeN/A
Average Volume (3M)212.00K
Market Cap
N/A
Enterprise ValueC$533.60K
Total Cash (Recent Filing)$12.37K
Total Debt (Recent Filing)$96.14K
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Aug 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding132,613,759
10 Day Avg. Volume0
30 Day Avg. Volume212,004
Standard Deviation0.36
R-Squared0.00502
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-1.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
22.11%
Insiders
0.00% Mutual Funds
7.14% Other Institutional Investors
70.75% Public Companies and
Individual Investors
PSYB.H FAQ
What was PsyBio Therapeutics’s price range in the past 12 months?
PsyBio Therapeutics lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.
What is PsyBio Therapeutics’s market cap?
Currently, no data Available
When is PsyBio Therapeutics’s upcoming earnings report date?
PsyBio Therapeutics’s upcoming earnings report date is Aug 26, 2024 which is 25 days ago.
How were PsyBio Therapeutics’s earnings last quarter?
Currently, no data Available
Is PsyBio Therapeutics overvalued?
According to Wall Street analysts PsyBio Therapeutics’s price is currently same.
Does PsyBio Therapeutics pay dividends?
PsyBio Therapeutics does not currently pay dividends.
What is PsyBio Therapeutics’s EPS estimate?
PsyBio Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PsyBio Therapeutics have?
PsyBio Therapeutics has 83,926,796 shares outstanding.
What happened to PsyBio Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PsyBio Therapeutics?
Currently, no hedge funds are holding shares in TSE:PSYB.H
---
PsyBio Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
PsyBio Therapeutics
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.
---
Technical Analysis
Numinus Wellness
―
Resverlogix
―
Mydecine Innovations Group
―
Revive Therapeutics
―
---